Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).

Volker Diehl, C. Brillant, J. Franklin, R. Hermann, R. Greil, A. Engert, B. Pfistner, for the German Hodgkin Lymphoma Study Group (GHSG), for the Competence Network Malignant Lymphoma.

Blood (2004) 104 (11): 307.

https://doi.org/10.1182/blood.V104.11.307.307

Published: 2004

Journal Articles

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner, for the German Hodgkin′s lymphoma study group (GHSG), the Competence Network Malignant Lymphoma.

Blood (2004) 104 (11): 1307.

https://doi.org/10.1182/blood.V104.11.1307.1307

Published: 2004

Journal Articles

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller Hermelink, R. Herrman, J. Markova, A. Ho, W. Hiddemann, B. Doerken, R. Greil, B. Pfistner, for the German Hodgkin′s Lymphoma Study Group (GHSG), the Competence Network Malignant Lymphoma.

Blood (2004) 104 (11): 1308.

https://doi.org/10.1182/blood.V104.11.1308.1308

Published: 2004

Journal Articles

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

M Cazzola, D Messinger, V Battistel, D Bron, R Cimino, L Enller-Ziegler, U Essers, R Greil, A Grossi, G Jager

Blood (1995) 86 (12): 4446–4453.

https://doi.org/10.1182/blood.V86.12.4446.bloodjournal86124446

Published: 1995

Journal Articles

Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis

R Greil, B Fasching, P Loidl, H Huber

Blood (1991) 78 (1): 180–191.

https://doi.org/10.1182/blood.V78.1.180.180

Published: 1991

NARROW

Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis

Email alerts

ASH Publications

American Society of Hematology

Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only